Telemark Asset Management LLC bought a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 1,700,000 shares of the company’s stock, valued at approximately $4,726,000.
A number of other institutional investors and hedge funds also recently modified their holdings of ASPI. Fielder Capital Group LLC acquired a new position in ASP Isotopes during the second quarter valued at approximately $55,000. Rhumbline Advisers acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $116,000. HTLF Bank grew its holdings in shares of ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of ASP Isotopes by 16.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares in the last quarter. Finally, Virtu Financial LLC raised its stake in ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares during the period. 16.80% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research analysts have issued reports on ASPI shares. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 target price for the company. HC Wainwright lowered their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Finally, Canaccord Genuity Group restated a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a report on Friday, October 18th.
ASP Isotopes Stock Performance
ASPI opened at $7.69 on Friday. The company has a market capitalization of $546.86 million, a price-to-earnings ratio of -11.93 and a beta of 3.88. The business’s 50-day moving average price is $4.75 and its two-hundred day moving average price is $3.80. ASP Isotopes Inc. has a 1 year low of $1.59 and a 1 year high of $9.33. The company has a debt-to-equity ratio of 2.06, a current ratio of 4.00 and a quick ratio of 4.00.
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last announced its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million during the quarter. ASP Isotopes had a negative net margin of 807.39% and a negative return on equity of 177.29%. Equities analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Featured Articles
- Five stocks we like better than ASP Isotopes
- 3 Best Fintech Stocks for a Portfolio Boost
- Tesla Investors Continue to Profit From the Trump Trade
- What is a Secondary Public Offering? What Investors Need to Know
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- 3 Warren Buffett Stocks to Buy Now
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI – Free Report).
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.